<DOC>
	<DOCNO>NCT00801866</DOCNO>
	<brief_summary>evaluate efficacy single intravitreal bevacizumab ( IVB ) injection , 0.1mL ( 2.5mg ) , panretinal photocoagulation ( PRP ) -induced macular thicken visual disturbance patient severe nonproliferative diabetic retinopathy ( NPDR ) proliferative diabetic retinopathy ( PDR ) good vision</brief_summary>
	<brief_title>Avastin Post-Photocoagulation Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients Proliferative retinopathy severe nonproliferative retinopathy BCVA 20/63 better ( 56 ETDRS letter No history Macular Edema Central Retinal Thickness 250mics Previous treatment . Other ophthalmic disease . history Nephropathy , heart diseases pregnancy Media opacity</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Panretinal Photocoagulation</keyword>
	<keyword>Macular Edema</keyword>
	<keyword>Intravitreal Bevacizumab</keyword>
</DOC>